Previous Article | Next Article ![]()
Journal of Virology, October 2008, p. 10321-10325, Vol. 82, No. 20
0022-538X/08/$08.00+0 doi:10.1128/JVI.01229-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Instituto de Biología Molecular y Celular de Plantas (CSIC-UPV), Avenida de los Naranjos, 46022 Valencia, Spain
Received 13 June 2008/ Accepted 4 August 2008
|
|
|---|
|
|
|---|
![]() View larger version (27K): [in a new window] |
FIG. 1. (A) Asymmetric rolling-circle replication cycle followed by members of the family Pospiviroidae that includes the kissing-loop interaction between two contiguous hairpin I motifs and the subsequent formation of a double-stranded structure proposed to be the substrate for cleavage (14). (B) Hairpin I and double-stranded structure corresponding to CEVd (+) RNA. Black arrowheads indicate the processing sites located 2 nt apart in each strand. Nucleotide numbering refers to CEVd sequence variant (with GenBank sequence number M34917) with a deleted G between positions 70 and 74.
|
5'- and 3'-RACE of the ml CEVd (+) RNA. An RNA preparation enriched in viroid RNAs was obtained by chromatography on nonionic cellulose CF11 (21) from an A. thaliana transgenic line expressing constitutively a dimeric head-to-tail CEVd (+) transcript (sequence variant with GenBank nucleotide sequence accession number M34917 with a deleted G between positions 70 and 74) starting at position 40 and ending at position 39 (6). The preparation was separated by double polyacrylamide gel electrophoresis (PAGE), first in native conditions and then in denaturing conditions (12), and the fraction of RNAs comigrating in the region of a ml CEVd (+) RNA standard purified from CEVd-infected gynura (Gynura aurantiaca DC) was eluted. Northern blot hybridization revealed that the ml (+) RNA was the only CEVd species present in the fraction (data not shown). To characterize the 5' terminus of the ml CEVd (+) RNA, three aliquots of this fraction were ligated to the adaptor oligoribonucleotide PI [5'-r(CGACUGGAGCACGAGGACACUGACAUGGACUGAAGGAGUA GAAA)-3', where r indicates that the sequence corresponds to an oligoribonucleotide] with T4 RNA ligase 1 (Epicentre) that requires 5'-P and 3'-OH termini. The first aliquot did not receive any previous treatment, while the second was pretreated with T4 polynucleotide kinase (Roche) and the third was pretreated with calf alkaline phosphatase (Roche). The ligation products were used as templates in reverse transcription (RT) reactions with Superscript III reverse transcriptase (Invitrogene) and the viroid-specific primer PII (5'-GCTTCAGCGACGATCGGATGTGGAGCC-3') complementary to CEVd sequence between positions 203 and 229 and then subjected to PCR amplification with the High Expand DNA polymerase mixture (Roche), an adaptor-specific primer PIII (5'-GGAGCACGAGGACACTGACATGG-3') with the same sequence as that underlined in PI and a nested viroid-specific primer PIV (5'-TTCTCCGCTGGACGCCAGTGATCCGC-3') complementary to CEVd sequence between positions 147 and 172 (Fig. 2A, left). Separation of RT-PCR products by PAGE showed amplification of a single prominent cDNA in the reaction mixture containing the untreated aliquot and in the mixture pretreated with polynucleotide kinase (Fig. 2B, lanes 1 and 3). Conversely, no amplification products were detected in the reaction mixture containing the aliquot pretreated with alkaline phosphatase (Fig. 2B, lane 2). The amplification products resulting from the untreated and polynucleotide kinase-treated aliquots were eluted from the gel and cloned in plasmid pTZ57R/T (Fermentas). Sequencing of several clones corresponding to each product showed that they were identical and consisted of a 115-bp DNA that, in addition to the adaptor, included the CEVd sequence from G97 to A172. This result confirmed that processing of the dimeric CEVd (+) RNA occurs between positions G96 and G97 as previously determined by primer extension (14), and it also showed that the resulting ml (+) RNA intermediate has a 5'-P terminus, since it was ligated to the adaptor without pretreatment with polynucleotide kinase but not after pretreatment with alkaline phosphatase.
![]() View larger version (37K): [in a new window] |
FIG. 2. Analysis of the 5' and 3' termini of the ml CEVd (+) RNA purified from transgenic A. thaliana expressing a dimeric CEVd (+) transcript. (A) Scheme depicting 5'- and 3'-RACE procedures. (B and C) RNA aliquots not treated or subjected to different pretreatments were subjected to 5'-RACE (B) and 3'-RACE (C), with the resulting products being separated by PAGE. Lane 0, control without RNA; lane 1, untreated RNA (Ø); lanes 2 and 3, RNA treated with alkaline phosphatase (AP) and polynucleotide kinase (PNK), respectively; lane M, DNA markers (M) with sizes (in base pairs) indicated to the right of the gels.
|
To characterize the 3' terminus of the ml CEVd (+) RNA purified from transgenic A. thaliana, two aliquots of the preparation were 3' polyadenylated with yeast poly(A) polymerase (USB) that adds AMP residues to an RNA with a terminal 3'-OH group. The first aliquot did not receive any previous treatment, while the second was pretreated with alkaline phosphatase. The polyadenylation products were subjected to RT with a poly(A) tail-complementary primer PV (5'-CCGGATCCTCTAGATCGGCCGCT17V-3', where V is A, C, or G) and to PCR amplification with this same primer and the CEVd-specific PVI primer (5'-GGAAACCTGGAGGAAGTCG-3') homologous to the CEVd sequence between positions 98 and 116 (Fig. 2A, right). PAGE separation of the resulting RT-PCR products showed the amplification of the same two DNAs in both reaction mixtures (Fig. 2C, lanes 1 and 2). The cDNAs amplified from the untreated RNA aliquot were eluted from the gel and cloned. Sequencing of several clones revealed that the largest and less abundant product was a 408-bp DNA including the CEVd sequence from G98 to U370 and from C1 to G96 and that the smaller and most abundant product was a 362-bp DNA including the CEVd sequence from G98 to U370 and from C1 to G50. The sequence of the largest amplification product confirmed again that processing of oligomeric CEVd (+) RNA in transgenic A. thaliana occurs between positions G96 and G97 (14). Moreover, since the ml CEVd (+) RNA was polyadenylated without any pretreatment, this RNA must contain a 3'-OH free terminus, together with the already characterized 5'-P. On the other hand, the sequence of the smaller amplification product predicted a second 3'-OH free terminus at position G50 that had not been detected in previous experiments (14). The observation that CEVd contains a poly(A)-rich sequence (positions 51 to 61) next to G50 suggests that the smaller amplification product most likely resulted from hybridization of the poly(dT) 3' tail of primer PV with this poly(A)-rich region and that, consequently, position G50 does not actually correspond to a ml CEVd (+) RNA terminus.
In vitro ligation assays. Next, the susceptibility of the ml CEVd (+) RNA purified from transgenic A. thaliana to be ligated by two enzymes with distinct specificities was assayed: the T4 RNA ligase 1 (Rnl1) that requires 5'-P and 3'-OH termini (9, 28, 29) and the A. thaliana tRNA ligase that requires 5'-OH and 2',3'>P termini (10) (Fig. 3A). Additionally, ml CEVd (+) RNA purified from CEVd-infected gynura, as well as RNA synthesized in vitro by transcription and subsequent treatment with tobacco acid pyrophosphatase (Epicentre)—resulting in a full-length ml CEVd (+) RNA from positions G97 to U370 and from C1 to G96 with 5'-P and 3'-OH termini—were used as a controls. Aliquots of these three RNAs that were either untreated, pretreated with alkaline phosphatase, or pretreated first with alkaline phosphatase and then with polynucleotide kinase were assayed for ligation with T4 RNA ligase 1 and A. thaliana tRNA ligase. For this purpose, a recombinant version of the latter (GenBank accession number NP_172269) with a carboxy-terminal His tag was expressed in Escherichia coli and purified. Ligation products were separated by denaturing PAGE and examined by Northern blot hybridization with a cRNA probe labeled with 32P. The ml CEVd (+) RNA from infected gynura was circularized by the T4 RNA ligase 1 in all instances (Fig. 3B, lanes 2 to 4), whereas that from transgenic A. thaliana was ligated when untreated (Fig. 3B, lane 5) or pretreated with alkaline phosphatase plus polynucleotide kinase (Fig. 3B, lane 7), but not when pretreated only with alkaline phosphatase (Fig. 3B, lane 6). The ml CEVd (+) RNA control synthesized in vitro with 5'-P and 3'-OH termini behaved similarly to the RNA from A. thaliana (Fig. 3B, lanes 8 to 10).
![]() View larger version (27K): [in a new window] |
FIG. 3. (A) Diagram depicting results of ligation by T4 RNA ligase 1 and A. thaliana tRNA ligase of two RNAs with different termini. (B and C) Ligation in vitro of ml CEVd (+) RNA purified from infected gynura and transgenic A. thaliana expressing a dimeric CEVd (+) transcript. Products generated by T4 RNA ligase 1 (B) and A. thaliana tRNA ligase (C) were separated by denaturing PAGE and analyzed by Northern blot hybridization. Prior to ligation, aliquots of ml CEVd (+) RNA from infected gynura (lanes 2 to 4) or transgenic A. thaliana (lanes 5 to 7) and ml CEVd (+) RNA synthesized in vitro with 5'-P and 3'-OH termini (lanes 8 to 10) were not treated (–) (lanes 2, 5, and 8) or pretreated (+) with alkaline phosphatase (AP) (lanes 3, 6, and 9) or pretreated (+) with alkaline phosphatase and polynucleotide kinase (PNK) (lanes 4, 7, and 10). Lane 1, RNA from infected gynura containing mc and ml CEVd (+) RNAs with their positions indicated to the left of the gels. The product with the lowest mobility in lanes 5 and 8 most likely corresponds to the dimeric linear CEVd RNA.
|
Termini of the native ml (+) RNAs from the family Pospiviroidae: comparison with previous data. The identification of 5'-P and 3'-OH termini in the ml (+) RNA intermediate processed in transgenic A. thaliana expressing a dimeric CEVd (+) transcript is consistent with data from an early report with Chrysanthemum stunt viroid, indicating that 72% of ml Chrysanthemum stunt viroid (+) RNA purified from infected plants contains a 5'-P terminus (23). In addition, ml CEVd (+) RNA with 5'-P and 3'-OH termini obtained by in vitro transcription and treatment with alkaline phosphatase and polynucleotide kinase was shown to be highly infectious (24). However, subsequent studies on the nature and biological significance of the ml PSTVd (+) RNA based on the 5'-end labeling of this species isolated from infected tissue (22), on its ligation in vitro by wheat germ and Chlamydomonas reinhardtii RNA ligases (3, 19), and on the infectivity of ml PSTVd (+) RNA produced by artificially nicking the circular forms (16) led to the proposal that the ml PSTVd (+) RNA intermediate has 5'-OH and 2',3'>P termini. However, the present results and those from a previous work aimed at characterizing the in vivo processing site of the oligomeric (+) RNAs of CEVd and two other members of the family Pospiviroidae (14) indicate that the ml CEVd (+) RNA population in transgenic A. thaliana is mostly homogeneous and representative of the product resulting from the processing in vivo of the dimeric transcript, possibly because viroid replication in this nonhost plant is low and RNA-RNA amplification of the mc CEVd (+) RNA is inefficient (6, 14). In contrast, in a host plant like gynura, the mc CEVd (+) RNA serves as a template for efficient RNA-RNA amplification and the population of the replicative intermediate ml CEVd (+) is contaminated with nicked by-products of the most abundant mc CEVd (+) RNA (14). Therefore, the experimental system based on transgenic A. thaliana offers the advantage that it can be programmed with a replication intermediate (6), and the fate of the intermediate can be monitored with little interference resulting from degradation of the mc viroid (+) RNA in vivo or in vitro during extraction and purification. Despite the fact that the present results suggest that the ml CEVd (+) RNA forms with 5'-OH and 2',3'>P termini from gynura arise from nicking of the most abundant mc CEVd (+) RNA, the possibility that a fraction of these molecules may participate in the replication cycle cannot be discarded.
Host factors involved in viroid RNA processing. In the family Avsunviroidae, hammerhead ribozymes catalyze self-cleavage of the oligomeric RNAs of both polarities in vivo (11). However, ribozyme-mediated RNA processing does not seem to operate in the family Pospiviroidae (27), and accordingly, the current consensus is that cleavage and ligation of the oligomeric (+) RNA intermediates are catalyzed by host enzymes. A good candidate to mediate cleavage is a type III RNase, because the 5'-P and 3'-OH termini identified here in the ml CEVd (+) RNA are those characteristically produced by these enzymes that act on double-stranded or highly structured RNA substrates (20). Moreover, some type III RNases cleave both strands of their substrates, generating products of approximately 20 bp with 2-nt 3'-protruding termini (15). A conserved double-stranded structure, formed by a kissing-loop interaction between two hairpin I motifs contiguous in the oligomeric (+) RNA, has been proposed as the substrate for cleavage, with the cleavage sites in each strand being 2 nt apart (Fig. 1) (14). To date, in A. thaliana, seven type III RNases have been described, including four Dicer-like proteins (DCL1 to DCL4) and three additional ones (RTL1 to RTL3) (4, 17). Regarding ligation, the resulting ml CEVd (+) RNA with 5'-P and 3'-OH termini is not a substrate of the tRNA ligase, the only plant RNA ligase described so far (10). Therefore, unless these termini are later modified, the present results suggest the existence of a second plant RNA ligase that would mediate joining of the same 5'-P and 3'-OH termini as those required by the T4 RNA ligases 1 and 2 (18, 24, 28, 29).
Published ahead of print on 13 August 2008. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»